A detailed history of Nilsine Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, Nilsine Partners, LLC holds 694 shares of AMGN stock, worth $194,285. This represents 0.03% of its overall portfolio holdings.

Number of Shares
694
Previous 747 7.1%
Holding current value
$194,285
Previous $233 Million 4.19%
% of portfolio
0.03%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$309.38 - $337.38 $16,397 - $17,881
-53 Reduced 7.1%
694 $224 Million
Q2 2024

Jul 31, 2024

BUY
$262.75 - $319.31 $196,274 - $238,524
747 New
747 $233 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Nilsine Partners, LLC Portfolio

Follow Nilsine Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nilsine Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nilsine Partners, LLC with notifications on news.